Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.56 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:30 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

nipro corp (NISOF) Snapshot

Open
--
Previous Close
$8.56
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
171.5M
EX-Date
09/28/15
P/E TM
--
Dividend
$34.34
Dividend Yield
3.34%
Current Stock Chart for NIPRO CORP (NISOF)

Related News

No related news articles were found.

nipro corp (NISOF) Related Businessweek News

View More BusinessWeek News

nipro corp (NISOF) Details

Nipro Corporation, together with its subsidiaries, engages in the medical equipment, pharmaceuticals, and glass businesses in Japan, the United States, Europe, and rest of Asia. The company’s Medical-Related Business segment offers injection and infusion products, artificial organ products, functional products, dialysis products, and diabetic products, as well as renal, intervention and anesthesiology, cardiopulmonary, and pharmaceutical kit products. Its Pharmaceutical-Related Business segment provides injectable drugs, including injection kits, etc.; oral drugs, such as orally-disintegrating tablets, etc.; generic anti-cancer drugs and biosimilars; and drugs for external use. The company’s Glass-Related Business segment offers tube glass for pharmaceuticals, vials, and ampoules; and glass material products for thermos bottles and lighting. Nipro Corporation is also involved in the rental of real estate properties. The company was founded in 1954 and is headquartered in Osaka, Japan.

Founded in 1954

nipro corp (NISOF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nipro corp (NISOF) Key Developments

Nipro Corporation, Annual General Meeting, Jun 26, 2015

Nipro Corporation, Annual General Meeting, Jun 26, 2015.

Nipro Corporation to Report Fiscal Year 2015 Results on May 13, 2015

Nipro Corporation announced that they will report fiscal year 2015 results on May 13, 2015

Nipro Corporation, 2015 Earnings Call, May 21, 2015

Nipro Corporation, 2015 Earnings Call, May 21, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NISOF:US $8.56 USD 0.00

NISOF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,742 INR +2.50
Fuso Pharmaceutical Industries Ltd ¥290.00 JPY -4.00
JMS Co Ltd ¥298.00 JPY -8.00
Nikkiso Co Ltd ¥1,239 JPY -38.00
NxStage Medical Inc $14.30 USD -0.04
View Industry Companies
 

Industry Analysis

NISOF

Industry Average

Valuation NISOF Industry Range
Price/Earnings 14.9x
Price/Sales 0.6x
Price/Book 1.2x
Price/Cash Flow 16.5x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NIPRO CORP, please visit www.nipro.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.